Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2012-11-13 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ATHESANS-ETROITEFONTAINE (70110), Haute-Saone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PHEULPIN BIENFAIT : revenue, balance sheet and financial ratios
PHARMACIE PHEULPIN BIENFAIT is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ATHESANS-ETROITEFONTAINE (70110),
this company of category PME
shows in 2016 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PHEULPIN BIENFAIT (SIREN 789326279)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 400 862 €
Net income
104 201 €
118 473 €
129 562 €
138 953 €
123 622 €
115 481 €
111 271 €
118 057 €
110 104 €
96 504 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
141 671 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
6.9%
Revenue and income statement
In 2025, PHARMACIE PHEULPIN BIENFAIT generates positive net income of 104 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 97 k€ -> 104 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
104 201 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
9.75%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
83.531%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
183.359
131.877
96.393
90.592
68.531
52.5
38.413
22.443
13.388
9.75
Financial autonomy
33.266
40.224
47.852
49.525
55.637
61.136
66.257
76.064
80.771
83.531
Repayment capacity
7.714
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
7.119%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
9.752025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of PHARMACIE PHEULPIN BIENFAIT (9.75) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
83.53%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE PHEULPIN BIENFAIT (83.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 509.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
505.606
466.065
531.805
536.079
514.274
517.733
467.415
546.401
475.814
509.036
Interest coverage
14.755
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
509.042025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of PHARMACIE PHEULPIN BIENFAIT (509.04) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PHEULPIN BIENFAIT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
103 131 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
22
0
0
0
0
0
0
0
0
0
Customer payment term (days)
6
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
13
0
0
0
0
0
0
0
0
0
Positioning of PHARMACIE PHEULPIN BIENFAIT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE PHEULPIN BIENFAIT is estimated at
1 655 245 €
(range 1 123 257€ - 2 597 307€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1123k€1655k€2597k€
1 655 245 €Range: 1 123 257€ - 2 597 307€
NAF 5 année 2025
Valuation method used
Net Income Multiple
104 201 €
×
15.9x
=1 655 245 €
Range: 1 123 257€ - 2 597 308€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PHEULPIN BIENFAIT with other companies in the same sector:
Frequently asked questions about PHARMACIE PHEULPIN BIENFAIT
What is the revenue of PHARMACIE PHEULPIN BIENFAIT ?
The revenue of PHARMACIE PHEULPIN BIENFAIT in 2016 is 1.4 M€.
Is PHARMACIE PHEULPIN BIENFAIT profitable?
Yes, PHARMACIE PHEULPIN BIENFAIT generated a net profit of 104 k€ in 2025.
Where is the headquarters of PHARMACIE PHEULPIN BIENFAIT ?
The headquarters of PHARMACIE PHEULPIN BIENFAIT is located in ATHESANS-ETROITEFONTAINE (70110), in the department Haute-Saone.
Where to find the tax return of PHARMACIE PHEULPIN BIENFAIT ?
The tax return of PHARMACIE PHEULPIN BIENFAIT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PHEULPIN BIENFAIT operate?
PHARMACIE PHEULPIN BIENFAIT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart